与芦可替尼相关的乙型肝炎病毒再激活 - Suppr

Hepatitis B virus reactivation associated with ruxolitinib.

作者信息

Shen Chien-Heng, Hwang Cih-En, Chen Yi-Yang, Chen Chih-Cheng

机构信息

Division of Gastroenterology, Department of Medicine, Chang Gung Memorial Hospital-Chiayi, Chiayi, Taiwan, Republic of China.

出版信息

Ann Hematol. 2014 Jun;93(6):1075-6. doi: 10.1007/s00277-013-1936-5. Epub 2013 Oct 31.

DOI:10.1007/s00277-013-1936-5

PMID:24173089

Abstract

摘要

相似文献

Hepatitis B virus reactivation associated with ruxolitinib.

Ann Hematol. 2014 Jun;93(6):1075-6. doi: 10.1007/s00277-013-1936-5. Epub 2013 Oct 31.

Occult hepatitis B infection reactivation after ruxolitinib therapy.

Dig Liver Dis. 2017 Jun;49(6):719. doi: 10.1016/j.dld.2017.03.004. Epub 2017 Mar 18.

Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis.

Leukemia. 2014 Jan;28(1):225-7. doi: 10.1038/leu.2013.235. Epub 2013 Aug 9.

Pulmonary tuberculosis reactivation following ruxolitinib treatment in a patient with primary myelofibrosis.

Leuk Lymphoma. 2015 May;56(5):1528-9. doi: 10.3109/10428194.2014.963082. Epub 2014 Nov 5.

Telbivudine.

Nat Rev Drug Discov. 2007 Apr;6(4):267-8. doi: 10.1038/nrd2295.

Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis.

Expert Rev Anti Infect Ther. 2017 May;15(5):503-513. doi: 10.1080/14787210.2017.1309291. Epub 2017 Mar 29.

Pneumocystis jiroveci pneumonitis complicating ruxolitinib therapy.

BMJ Case Rep. 2014 Jun 2;2014:bcr2014204950. doi: 10.1136/bcr-2014-204950.

Elevation of the Hepatitis B Virus DNA during the Treatment of Polycythemia Vera with the JAK Kinase Inhibitor Ruxolitinib.

Intern Med. 2016;55(10):1341-4. doi: 10.2169/internalmedicine.55.5529. Epub 2016 May 15.

Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma.

Blood. 2002 Jan 15;99(2):724-5. doi: 10.1182/blood.v99.2.724.

[Entecavir therapy against hepatitis B].

Nihon Rinsho. 2004 Aug;62 Suppl 8:340-4.

引用本文的文献

Risk of hepatitis B reactivation in patients with myeloproliferative neoplasms treated with ruxolitinib.

World J Hepatol. 2023 Nov 27;15(11):1188-1195. doi: 10.4254/wjh.v15.i11.1188.

Typical hemophagocytic syndrome associated with cytomegalovirus infection in an immunocompetent patient: a case report and literature review.

J Zhejiang Univ Sci B. 2023 Dec 15;24(12):1159-1164. doi: 10.1631/jzus.B2300232.

Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors.

Front Immunol. 2021 Nov 19;12:750346. doi: 10.3389/fimmu.2021.750346. eCollection 2021.

Ruxolitinib-Associated Infections in Polycythemia Vera: Review of the Literature, Clinical Significance, and Recommendations.

Cancers (Basel). 2020 Oct 26;12(11):3132. doi: 10.3390/cancers12113132.

A case report of cryptococcal meningitis associated with ruxolitinib.

Medicine (Baltimore). 2020 Mar;99(13):e19587. doi: 10.1097/MD.0000000000019587.

Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies.

Pharmacotherapy. 2019 Dec;39(12):1190-1203. doi: 10.1002/phar.2340. Epub 2019 Nov 3.

Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention.

World J Gastroenterol. 2019 Jul 14;25(26):3299-3312. doi: 10.3748/wjg.v25.i26.3299.

Reactivation of hepatitis B virus infection in patients with hematologic disorders.

Haematologica. 2019 Mar;104(3):435-443. doi: 10.3324/haematol.2018.210252. Epub 2019 Feb 7.

Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL).

Leukemia. 2019 Apr;33(4):844-862. doi: 10.1038/s41375-019-0388-x. Epub 2019 Jan 30.

Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor.

Ther Clin Risk Manag. 2017 Feb 13;13:169-177. doi: 10.2147/TCRM.S121683. eCollection 2017.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Hepatitis B virus reactivation associated with ruxolitinib.

作者信息

Shen Chien-Heng, Hwang Cih-En, Chen Yi-Yang, Chen Chih-Cheng

机构信息

Division of Gastroenterology, Department of Medicine, Chang Gung Memorial Hospital-Chiayi, Chiayi, Taiwan, Republic of China.

出版信息

Ann Hematol. 2014 Jun;93(6):1075-6. doi: 10.1007/s00277-013-1936-5. Epub 2013 Oct 31.

DOI:10.1007/s00277-013-1936-5

PMID:24173089

Abstract

摘要

相似文献

Hepatitis B virus reactivation associated with ruxolitinib.

Ann Hematol. 2014 Jun;93(6):1075-6. doi: 10.1007/s00277-013-1936-5. Epub 2013 Oct 31.

Occult hepatitis B infection reactivation after ruxolitinib therapy.

Dig Liver Dis. 2017 Jun;49(6):719. doi: 10.1016/j.dld.2017.03.004. Epub 2017 Mar 18.

Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis.

Leukemia. 2014 Jan;28(1):225-7. doi: 10.1038/leu.2013.235. Epub 2013 Aug 9.

Pulmonary tuberculosis reactivation following ruxolitinib treatment in a patient with primary myelofibrosis.

Leuk Lymphoma. 2015 May;56(5):1528-9. doi: 10.3109/10428194.2014.963082. Epub 2014 Nov 5.

Telbivudine.

Nat Rev Drug Discov. 2007 Apr;6(4):267-8. doi: 10.1038/nrd2295.

Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis.

Expert Rev Anti Infect Ther. 2017 May;15(5):503-513. doi: 10.1080/14787210.2017.1309291. Epub 2017 Mar 29.

Pneumocystis jiroveci pneumonitis complicating ruxolitinib therapy.

BMJ Case Rep. 2014 Jun 2;2014:bcr2014204950. doi: 10.1136/bcr-2014-204950.

Elevation of the Hepatitis B Virus DNA during the Treatment of Polycythemia Vera with the JAK Kinase Inhibitor Ruxolitinib.

Intern Med. 2016;55(10):1341-4. doi: 10.2169/internalmedicine.55.5529. Epub 2016 May 15.

Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma.

Blood. 2002 Jan 15;99(2):724-5. doi: 10.1182/blood.v99.2.724.

[Entecavir therapy against hepatitis B].

Nihon Rinsho. 2004 Aug;62 Suppl 8:340-4.

引用本文的文献

Risk of hepatitis B reactivation in patients with myeloproliferative neoplasms treated with ruxolitinib.

World J Hepatol. 2023 Nov 27;15(11):1188-1195. doi: 10.4254/wjh.v15.i11.1188.

Typical hemophagocytic syndrome associated with cytomegalovirus infection in an immunocompetent patient: a case report and literature review.

J Zhejiang Univ Sci B. 2023 Dec 15;24(12):1159-1164. doi: 10.1631/jzus.B2300232.

Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors.

Front Immunol. 2021 Nov 19;12:750346. doi: 10.3389/fimmu.2021.750346. eCollection 2021.

Ruxolitinib-Associated Infections in Polycythemia Vera: Review of the Literature, Clinical Significance, and Recommendations.

Cancers (Basel). 2020 Oct 26;12(11):3132. doi: 10.3390/cancers12113132.

A case report of cryptococcal meningitis associated with ruxolitinib.

Medicine (Baltimore). 2020 Mar;99(13):e19587. doi: 10.1097/MD.0000000000019587.

Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies.

Pharmacotherapy. 2019 Dec;39(12):1190-1203. doi: 10.1002/phar.2340. Epub 2019 Nov 3.

Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention.

World J Gastroenterol. 2019 Jul 14;25(26):3299-3312. doi: 10.3748/wjg.v25.i26.3299.

Reactivation of hepatitis B virus infection in patients with hematologic disorders.

Haematologica. 2019 Mar;104(3):435-443. doi: 10.3324/haematol.2018.210252. Epub 2019 Feb 7.

Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL).

Leukemia. 2019 Apr;33(4):844-862. doi: 10.1038/s41375-019-0388-x. Epub 2019 Jan 30.

Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor.

Ther Clin Risk Manag. 2017 Feb 13;13:169-177. doi: 10.2147/TCRM.S121683. eCollection 2017.

Hepatitis B virus reactivation associated with ruxolitinib.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Hepatitis B virus reactivation associated with ruxolitinib.

作者信息

机构信息

出版信息

相似文献

引用本文的文献